Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form
As of April 1st VIVO Scientific Profiles will no longer updated for faculty, and the link to VIVO will be removed from the library website. Faculty profile pages will continue to be updated via Interfolio. VIVO will continue being used behind the scenes to update graduate student profiles. Please contact helplib@scripps.edu if you have questions.
How to download citations from VIVO | Alternative profile options

Sequential activation of the MEK-extracellular signal-regulated kinase and MKK3/6-p38 mitogen-activated protein kinase pathways mediates oncogenic ras-induced premature senescence

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Wang, W. P.
  • Chen, J. X.
  • Liao, R.
  • Deng, Q. D.
  • Zhou, J. J.
  • Huang, S.
  • Sun, Peiqing

publication date

  • May 2002

journal

  • Molecular and Cellular Biology  Journal

abstract

  • In primary mammalian cells, oncogenic ras induces premature senescence, depending on an active MEK-extracellular signal-regulated kinase (ERK) mitogen-activated protein kinase (MAPK) pathway. It has been unclear how activation of the mitogenic MEK-ERK pathway by ras can confer growth inhibition. In this study, we have found that the stress-activated MAPK, p38, is also activated during the onset of ras-induced senescence in primary human fibroblasts. Constitutive activation of p38 by active MKK3 or MKK6 induces senescence. Oncogenic ras fails to provoke senescence when p38 activity is inhibited, suggesting that p38 activation is essential for ras-induced senescence. Furthermore, we have demonstrated that p38 activity is stimulated by ras as a result of an activated MEK-ERK pathway. Following activation of MEK and ERK, expression of oncogenic ras leads to the accumulation of active MKK3/6 and p38 activation in a MEK-dependent fashion and subsequently induces senescence. Active MEK1 induces the same set of changes and provokes senescence relying on active p38. Therefore, oncogenic ras provokes premature senescence by sequentially activating the MEK-ERK and MKK3/6-p38 pathways in normal, primary cells. These studies have defined the molecular events within the ras signaling cascade that lead to premature senescence and, thus, have provided new insights into how ras confers oncogenic transformation in primary cells.

subject areas

  • Calcium-Calmodulin-Dependent Protein Kinases
  • Cell Aging
  • Cell Size
  • Cells, Cultured
  • Cyclin-Dependent Kinase Inhibitor p16
  • Enzyme Activation
  • Fibroblasts
  • Genes, ras
  • Humans
  • MAP Kinase Kinase 3
  • MAP Kinase Kinase 6
  • MAP Kinase Kinase Kinase 1
  • MAP Kinase Signaling System
  • Mitogen-Activated Protein Kinase Kinases
  • Mitogen-Activated Protein Kinases
  • Protein Serine-Threonine Kinases
  • Protein-Tyrosine Kinases
  • Tumor Necrosis Factor-alpha
  • p38 Mitogen-Activated Protein Kinases
scroll to property group menus

Identity

PubMed Central ID

  • PMC133789

International Standard Serial Number (ISSN)

  • 0270-7306

Digital Object Identifier (DOI)

  • 10.1128/mcb.22.10.3389-3403.2002

PubMed ID

  • 11971971
scroll to property group menus

Additional Document Info

start page

  • 3389

end page

  • 3403

volume

  • 22

issue

  • 10

©2022 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support